126 related articles for article (PubMed ID: 28300577)
1. PGE
Zang S; Ma X; Wu Y; Liu W; Cheng H; Li J; Liu J; Huang A
Hum Pathol; 2017 May; 63():120-127. PubMed ID: 28300577
[TBL] [Abstract][Full Text] [Related]
2. [Prostaglandin E2 promotes hepatocellular carcinoma cell proliferation through EP2 prostanoid receptor].
Guo D; Chen NN; Hou LB; Lei LS
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Sep; 31(9):1564-7. PubMed ID: 21945767
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the prostaglandin E receptor EP2 in paeoniflorin-induced human hepatoma cell apoptosis.
Hu S; Sun W; Wei W; Wang D; Jin J; Wu J; Chen J; Wu H; Wang Q
Anticancer Drugs; 2013 Feb; 24(2):140-9. PubMed ID: 23069790
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E2 promotes the cell growth and invasive ability of hepatocellular carcinoma cells by upregulating c-Myc expression via EP4 receptor and the PKA signaling pathway.
Xia S; Ma J; Bai X; Zhang H; Cheng S; Zhang M; Zhang L; Du M; Wang Y; Li H; Rong R; Shi F; Yang Q; Leng J
Oncol Rep; 2014 Oct; 32(4):1521-30. PubMed ID: 25109834
[TBL] [Abstract][Full Text] [Related]
5. Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting COX-2/PGE2-regulated activation of the β-catenin signaling pathway.
Li T; Zhong J; Dong X; Xiu P; Wang F; Wei H; Wang X; Xu Z; Liu F; Sun X; Li J
Oncol Rep; 2016 Jun; 35(6):3614-22. PubMed ID: 27109804
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of the S1P
Filipenko I; Schwalm S; Reali L; Pfeilschifter J; Fabbro D; Huwiler A; Zangemeister-Wittke U
Biochim Biophys Acta; 2016 Nov; 1861(11):1840-1851. PubMed ID: 27616330
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E₂ receptor EP2 mediates Snail expression in hepatocellular carcinoma cells.
Cheng SY; Zhang H; Zhang M; Xia SK; Bai XM; Zhang L; Ma J; Rong R; Wang YP; Du MZ; Wang J; Chen M; Shi F; Yang QY; Leng J
Oncol Rep; 2014 May; 31(5):2099-106. PubMed ID: 24626807
[TBL] [Abstract][Full Text] [Related]
8. Cryptotanshinone (Dsh-003) from Salvia miltiorrhiza Bunge inhibits prostaglandin E2-induced survival and invasion effects in HA22T hepatocellular carcinoma cells.
Chang JH; Lin CH; Shibu MA; Chou YC; Liu JY; Chou YH; Shen CY; Yeh YL; Viswanadha VP; Huang CY
Environ Toxicol; 2018 Dec; 33(12):1254-1260. PubMed ID: 30208247
[TBL] [Abstract][Full Text] [Related]
9. Synergetic Effect of EP1 Receptor Antagonist and (-)-Epigallocatechin-3-gallate in Hepatocellular Carcinoma.
Yang H; Wang M; Sun H; Zhu S; Jin J
Pharmacology; 2019; 104(5-6):267-275. PubMed ID: 31434088
[TBL] [Abstract][Full Text] [Related]
10. Prostanoid EP1 receptor as the target of (-)-epigallocatechin-3-gallate in suppressing hepatocellular carcinoma cells in vitro.
Jin J; Chang Y; Wei W; He YF; Hu SS; Wang D; Wu YJ
Acta Pharmacol Sin; 2012 May; 33(5):701-9. PubMed ID: 22555372
[TBL] [Abstract][Full Text] [Related]
11. SPHK1 inhibitor suppresses cell proliferation and invasion associated with the inhibition of NF-κB pathway in hepatocellular carcinoma.
Zhang Z; Yan Z; Yuan Z; Sun Y; He H; Mai C
Tumour Biol; 2015 Mar; 36(3):1503-9. PubMed ID: 25537088
[TBL] [Abstract][Full Text] [Related]
12. Pioglitazone, a PPARγ agonist, inhibits growth and invasion of human hepatocellular carcinoma via blockade of the rage signaling.
Yang Y; Zhao LH; Huang B; Wang RY; Yuan SX; Tao QF; Xu Y; Sun HY; Lin C; Zhou WP
Mol Carcinog; 2015 Dec; 54(12):1584-95. PubMed ID: 25307746
[TBL] [Abstract][Full Text] [Related]
13. Upregulated HOXC8 Expression Is Associated with Poor Prognosis and Oxaliplatin Resistance in Hepatocellular Carcinoma.
Xu P; Zhang X; Ni W; Fan H; Xu J; Chen Y; Zhu J; Gu X; Yang L; Ni R; Chen B; Shi W
Dig Dis Sci; 2015 Nov; 60(11):3351-63. PubMed ID: 26123838
[TBL] [Abstract][Full Text] [Related]
14. Silymarin suppresses the PGE2 -induced cell migration through inhibition of EP2 activation; G protein-dependent PKA-CREB and G protein-independent Src-STAT3 signal pathways.
Woo SM; Min KJ; Chae IG; Chun KS; Kwon TK
Mol Carcinog; 2015 Mar; 54(3):216-28. PubMed ID: 24127286
[TBL] [Abstract][Full Text] [Related]
15. Actinidia chinensis Planch root extract (acRoots) inhibits hepatocellular carcinoma progression by inhibiting EP3 expression.
Fang T; Hou J; He M; Wang L; Zheng M; Wang X; Xia J
Cell Biol Toxicol; 2016 Dec; 32(6):499-511. PubMed ID: 27475644
[TBL] [Abstract][Full Text] [Related]
16. Characterization and regulation of prostaglandin E2 receptor and receptor-coupled functions in the choroidal vasculature of the pig during development.
Abran D; Dumont I; Hardy P; Peri K; Li DY; Molotchnikoff S; Varma DR; Chemtob S
Circ Res; 1997 Apr; 80(4):463-72. PubMed ID: 9118476
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E2 stimulates β1-integrin expression in hepatocellular carcinoma through the EP1 receptor/PKC/NF-κB pathway.
Bai X; Wang J; Guo Y; Pan J; Yang Q; Zhang M; Li H; Zhang L; Ma J; Shi F; Shu W; Wang Y; Leng J
Sci Rep; 2014 Oct; 4():6538. PubMed ID: 25289898
[TBL] [Abstract][Full Text] [Related]
18. Madecassoside suppresses proliferation and invasiveness of HGF-induced human hepatocellular carcinoma cells via PKC-cMET-ERK1/2-COX-2-PGE2 pathway.
Li Z; You K; Li J; Wang Y; Xu H; Gao B; Wang J
Int Immunopharmacol; 2016 Apr; 33():24-32. PubMed ID: 26851630
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2 promotes hepatocellular carcinoma cell invasion through upregulation of YB-1 protein expression.
Zhang H; Cheng S; Zhang M; Ma X; Zhang L; Wang Y; Rong R; Ma J; Xia S; Du M; Shi F; Wang J; Yang Q; Bai X; Leng J
Int J Oncol; 2014 Mar; 44(3):769-80. PubMed ID: 24378923
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E2 promotes human cholangiocarcinoma cell proliferation, migration and invasion through the upregulation of β-catenin expression via EP3-4 receptor.
Du M; Shi F; Zhang H; Xia S; Zhang M; Ma J; Bai X; Zhang L; Wang Y; Cheng S; Yang Q; Leng J
Oncol Rep; 2015 Aug; 34(2):715-26. PubMed ID: 26058972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
